2014 AfterCare Education Day Archives

2014 AfterCare Education Day

Posted on March 6, 2014 by admin

POGO’s 2014 AfterCare Education Day examined selected clinical and psychosocial issues impacting childhood cancer survivors and provided delegates with theoretical knowledge and practical strategies to manage these issues in order to improve care provided to survivors of pediatric cancers. Over 90 pediatric oncologists, nurses, social workers, and other provincial interdisciplinary AfterCare staff working with childhood cancer survivors attended in order to enhance their knowledge of late effects associated with childhood cancer and to be exposed to new strategies to manage this unique patient population.

VIEW THE PROGRAM

NOTE: The content of each presentation below captures the unedited information and opinions presented by the speakers. Please note that the information contained in the presentations was current at the time it was presented – there may be further information in subsequent literature. Listed speaker credentials were current at the time of presentation.

Impact of Contemporary ALL Protocols on Neurocognitive Outcomes
Kevin Krull, PhD

Harmonization of Health Screening and Surveillance Guidelines for Childhood Cancer Survivors
Melissa Hudson, MD

Long-Term Health-Related Outcomes in Survivors of Childhood Hematopoietic Cell Transplantation
Saro Armenian, DO, MPH

Benefits and Implementation in Long-Term Childhood Cancer Survivors
Oren Cheifetz, PhD

Finding the Line: Discussing Optimal Care of Obese Childhood Cancer Survivors
Beth Dettmer, PhD, C. Psych; Jill Hamilton, MD, FRCPC; Alene Toulany, MD, FRCPC; Tania Turrini, BSc, RD

The St. Jude Lifetime Cohort: Lessons Learned
Melissa Hudson, MD

Interactive Group Discussion – Looking Through the “Retrospectoscope”: Discussing the Burden of Curing
Moderator: Jonathan Hellmann, MBBCh, FCP, FRCPC

Impact of Contemporary ALL Protocols on Neurocognitive Outcomes

Posted on March 6, 2014 by admin

Presentation Description:
Long-term survivors of childhood acute lymphoblastic leukemia are at risk for development of chronic health problems, including neurocognitive impairment. Cranial radiation therapy has long been recognized as a risk factor for these neurocognitive problems, and has been removed from many contemporary therapeutic protocols, being replaced by intensified chemotherapy doses. This presentation reported recent findings linking chemotherapy to neurocognitive impairment and brain integrity. The developmental course of neurocognitive function was reviewed in a longitudinal study and risk factors discussed. Implications for follow-up and intervention were also reviewed.

Speaker:

Kevin Krull, PhD
Faculty Member
St. Jude Children’s Research Hospital, Memphis

Harmonization of Health Screening and Surveillance Guidelines for Childhood Cancer Survivors

Posted on March 6, 2014 by admin

Presentation Description:
Clinical practice guidelines are essential to ensure that childhood and young adult cancer survivors receive health care that addresses their unique health risks. Over the last decade, several groups have worked independently to develop and maintain clinical practice guidelines for this medically vulnerable population. Recognizing the potential benefits of collaboration, the International Late Effects of Childhood Cancer Guideline Harmonization Group was established in 2010 as an endeavor to harmonize clinical practice guidelines for survivors of childhood and young adult cancer. This presentation described the history of the International Late Effects of Childhood Cancer Guideline Harmonization Group collaboration, the methods used in the harmonization process, and their progress accomplished to date.

Speaker:

Melissa Hudson, MD
Director, Division of Cancer Survivorship
St. Jude Children’s Research Hospital, Memphis

Long-Term Health-Related Outcomes in Survivors of Childhood Hematopoietic Cell Transplantation

Posted on March 6, 2014 by admin

Presentation Description:
HCT is frequently offered as a curative option for children with benign and malignant conditions. Improvements in HCT strategies have increased survival by approximately 10% per decade. In fact, long-term survival is an expected outcome for many children and adolescents who undergo HCT. The growing population of long-term survivors has brought to the medical forefront a host of chronic and debilitating conditions attributed to toxicity from pre-transplantation exposure, transplantation conditioning regimens, chronic immunosuppression, and GVHD. This presentation provided an overview of health-related outcomes in long-term survivors of childhood HCT, and compared these outcomes to survivors of conventionally treated cancer.

Speaker:

Saro Armenian, DO, MPH
Medical Director, Pediatric Survivorship Clinic, Childhood Cancer Survivorship Program
City of Hope, Los Angeles

Exercise: Benefits and Implementation in Long-Term Childhood Cancer Survivors

Posted on March 6, 2014 by admin

Presentation Description:
Emphasis on cancer survivorship is increasing yearly both for adults and children diagnosed with cancer. The incorporation of exercise as a standard component of cancer therapy has not yet been established. However a growing amount of research is directed at investigating the effects of exercise on cancer survivors. This presentation summarized recent evidence supporting incorporation of exercise following cancer diagnosis, reviewed exercise safety considerations and highlighted the CanWell Exercise and Education program for cancer survivors.

Speaker:

Oren Cheifetz, PhD
Clinical Specialist in Physiotherapy, Hamilton Health Sciences
Canadian Cancer Rehabilitation and Education Institute (CCREI)

Blog